blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4267722

EP4267722 - DIFFUSION GRADIENT ASSAY FOR ANTI-CD3-CONTAINING MOLECULES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  29.09.2023
Database last updated on 05.10.2024
FormerThe international publication has been made
Status updated on  02.07.2022
Formerunknown
Status updated on  20.02.2022
Most recent event   Tooltip23.02.2024Change: Validation statespublished on 27.03.2024  [2024/13]
23.02.2024Change - extension statespublished on 27.03.2024  [2024/13]
Applicant(s)For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320 / US
For all designated states
Amgen Research (Munich) GmbH
Staffelseestrasse 2
81477 München / DE
[2023/44]
Inventor(s)01 / TAN, Glenn, Christopher
Thousand Oaks, CA 91320-1799 / US
02 / ZASADZINSKA, Ewelina
Thousand Oaks, CA 91320-1799 / US
03 / HOFFMANN, Patrick
81477 Munich / DE
04 / WU, Bin
Thousand Oaks, CA 91320-1799 / US
 [2023/44]
Representative(s)Lau, Sarah Jane, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2023/44]
Application number, filing date21854953.321.12.2021
[2023/44]
WO2021US64546
Priority number, dateUS202063128959P22.12.2020         Original published format: US 202063128959 P
[2023/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022140344
Date:30.06.2022
Language:EN
[2022/26]
Type: A1 Application with search report 
No.:EP4267722
Date:01.11.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 30.06.2022 takes the place of the publication of the European patent application.
[2023/44]
Search report(s)International search report - published on:EP30.06.2022
ClassificationIPC:C12N5/00, B01L3/00, C12M1/00, G01N21/64
[2023/44]
CPC:
C12N5/0075 (EP,US); C12M23/16 (US); B01L2200/0668 (EP);
B01L2300/0896 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/44]
TitleGerman:DIFFUSIONSGRADIENTTEST FÜR ANTI-CD3-HALTIGE MOLEKÜLE[2023/44]
English:DIFFUSION GRADIENT ASSAY FOR ANTI-CD3-CONTAINING MOLECULES[2023/44]
French:ESSAI PAR GRADIENT DE DIFFUSION POUR DES MOLÉCULES CONTENANT UN ANTI-CD3[2023/44]
Entry into regional phase04.07.2023National basic fee paid 
04.07.2023Designation fee(s) paid 
04.07.2023Examination fee paid 
Examination procedure04.07.2023Examination requested  [2023/44]
04.07.2023Date on which the examining division has become responsible
12.02.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
19.12.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[I]WO2017117521  (BERKELEY LIGHTS INC [US], et al) [I] 1-24 * abstract * * pages 3-4, paragraph 6 * * page 21, paragraph 82 * * pages 61-62, paragraphs 202-205 * * pages 63-64, paragraphs 209,210 * * pages 82-84; examples 9,10 * * page 86; example 16 *;
 [I]WO2018076024  (PARK MINHA [US], et al) [I] 1-24 * abstract * * page 2, paragraph 5 ** page 18, paragraph 93 *;
 [I]WO2018126205  (MARSON ALEX [US], et al) [I] 1-24 * abstract * * page 2, paragraph 5 * * page 60, paragraph 204 * * pages 61-62, paragraph 208 * * pages 72-73, paragraph 238 * * page 74, paragraph 241 * * page 75, paragraph 243 * * page 78, paragraph 248 * * pages 90-91, paragraphs 291-294 *;
 [I]  - ZHANG WEIKAI ET AL, "A microfluidic chip for screening high-producing hybridomas at single cell level", LAB ON A CHIP, UK, vol. 20, no. 21, doi:10.1039/D0LC00847H, ISSN 1473-0197, (20201027), pages 4043 - 4051, URL: https://pubs.rsc.org/en/content/articlepdf/2020/lc/d0lc00847h, XP055915000 [I] 1-24 * abstract * * page 4044, column l, paragraph 3 * * page 4045, column r, paragraph l - page 4048, column l, paragraph 1 *

DOI:   http://dx.doi.org/10.1039/D0LC00847H
by applicant   - WURM, F. M., Nat Biotechnol, (20040000), no. 11, pages 1393 - 8
    - FRYE, C. et al., Biologicals, (20160000), vol. 44, no. 2, pages 117 - 22
    - LE KTAN CLE H et al., "Assuring Clonality on the Beacon Digital Cell Line Development Platform", Biotechnol, (20200000), vol. 15, no. 1, doi:10.1002/biot.201900247, page 900247, XP055757553

DOI:   http://dx.doi.org/10.1002/biot.201900247
    - WURM, F. M., Nat Biotechnol.
    - LE K et al., Biotechnol Prog., (20180000), vol. 34, no. 6, pages 1438 - 1446
    - LE K et al., Biotechnol J., (20200000), vol. 15, no. l, page el900247
    - BAEUERLE PA et al., Curr Opin Mol Ther, (20090000), vol. 11, no. 1, pages 22 - 30
    - FRANKEL SRBAEUERLE PA, Curr Opin Chem Biol., (20130000), vol. 17, no. 3, pages 385 - 392
    - YURASZECK T et al., Clin Pharmacol Ther., (20170000), vol. 101, no. 5, pages 634 - 645
    - BAEUERLE PA et al., Curr Opin Mol Ther., (20090000), vol. 11, no. 1, pages 22 - 30
    - LOVE et al., Nat. Biotechnol., (20060000), vol. 24, no. 6, page 703
    - OZKUMUR et al., Materials Views, (20150000), vol. 11, no. 36, pages 4643 - 4650
    - "UniProt", Database accession no. P07766
    - CLEVERS et al., Proc. Natl. Acad. Sci., (19880000), vol. 85, pages 8156 - 8160
    - BORROTO et al., J. Immunol., (19990000), vol. 163, no. 1, pages 25 - 31
    - SEIMETZ et al., Cancer Treat Rev, (20100000), vol. 36, no. 6, pages 458 - 67
    - "Downstream Processing of Fc Fusion Proteins, Bispecific Antibodies, and Antibody-Drug Conjugates", SHULKANORMAN, Process Scale Purification of, John Wiley & Sons, (20170000), pages 559 - 594
    - MOORE et al., MAbs, (20110000), vol. 3, no. 6, pages 546 - 557
    - COLOMA, M.J., Nature Biotech., (19970000), vol. 15, pages 159 - 163
    - LEHNINGE, Biochemistry, Worth Publishers, Inc., (19750000), pages 71 - 77
    - GRAHAM et al., J. Gen Virol, (19770000), vol. 36, page 59
    - Mather, Biol. Reprod., (19800000), vol. 23, pages 243 - 251
    - MATHER et al., Annals N.Y Acad. Sci., (19820000), vol. 383, pages 44 - 68
    - DESIGN, Berkeley Lights, vol. 1758
    - LE K et al., Biotechnol J, (20200000), vol. 15, no. l, page el900247
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.